Physician profile
Thomas Lee
NPI 1659357911
$15,242.36
in general payments reported to CMS, 2019-2025
36 companies · $2,740 in 2025
The $2,740 reported for 2025 was more than what 89% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,341 · 2020: $602 · 2021: $2,909 · 2022: $1,643 · 2023: $3,492 · 2024: $2,515 · 2025: $2,740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,846 · Travel and Lodging: $2,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,846.00 |
| Travel and Lodging | $2,901.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $4,047.80 | 2019-2024 | Senza |
| Spr Therapeutics, INC | $3,183.05 | 2020-2025 | Sprint Pns System |
| Relievant Medsystems, INC. | $1,798.56 | 2021-2022 | |
| Boston Scientific Corporation | $1,189.80 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Pacira Pharmaceuticals Incorporated | $1,084.30 | 2024-2025 | Iovera, Exparel |
| Si-Bone, INC. | $904.65 | 2019-2024 | |
| Globus Medical, INC. | $739.79 | 2025 | Senza, Vyrsa V1 |
| Merz Pharmaceuticals, LLC | $349.98 | 2023-2025 | Xeomin |
| Nalu Medical, INC. | $275.88 | 2021-2024 | Nalu Neurostimulation System |
| Abbvie INC. | $269.34 | 2022-2025 | |
| Stryker Corporation | $249.95 | 2019-2025 | Optablate |
| Stratus Medical, LLC | $146.22 | 2025 | Nimbus |
| Trice Medical, INC. | $112.41 | 2022 | |
| Curonix LLC | $102.70 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Bioventus LLC | $96.66 | 2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $85.51 | 2024-2025 | Floseal |
| Averitas Pharma INC. | $73.03 | 2023-2024 | Qutenza |
| Allergan, INC. | $67.38 | 2019-2020 | |
| Avanos Medical | $59.89 | 2024 | Generator |
| Upsher-Smith Laboratories LLC | $43.31 | 2021 | |
| Collegium Pharmaceutical, INC. | $42.72 | 2025 | Belbuca |
| Revance Therapeutics, INC. | $36.98 | 2024 | Daxxify |
| 4web, INC. | $25.25 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $23.64 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $22.35 | 2024 | Dysport |
| Native Surgical, LLC | $22.00 | 2025 | |
| Eisai INC. | $21.99 | 2021 | |
| Electronic Waveform Lab, INC. | $21.78 | 2019-2023 | |
| Spinal Simplicity, LLC | $21.24 | 2025 | Ha Minuteman G3-R |
| Biohaven Pharmaceuticals, INC. | $20.97 | 2021 | |
| Abbott Laboratories | $19.90 | 2019 | |
| Neurocrine Biosciences, INC. | $19.55 | 2023 | Ingrezza, Ongentys |
| Axsome Therapeutics, INC. | $17.26 | 2025 | Symbravo |
| Avanir Pharmaceuticals, INC. | $16.70 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $15.55 | 2024 | Nuedexta |
| International Rehabilitative Sciences, INC | $14.27 | 2025 | Rs-4i Plus With Intersperse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.